1 in 4 black men will be diagnosed with prostate cancer in their lifetime, double the 1 in 8 risk faced by all men. We don’t know why, but you can help us find out.
These precision drugs are the biggest breakthroughs we’ve seen in decades for extending the lives of men with advanced prostate cancer.
The last year saw the announcement of the world’s first precision medicine for prostate cancer and huge progress towards the development of a home urine test. Just some of the things that made 2019 one of the most innovative years in prostate cancer research history.
This week’s results offer a brand-new precision treatment option for a group of men with particularly aggressive forms of advanced prostate cancer.
News of a new prostate cancer test hit the headlines yesterday. It’s a promising step forward in improving diagnosis, but is there enough research to show the test could be accurate enough to end the need for biopsy?
The news features a ‘ten-minute MRI scan’ which could be rolled out in future across the country as part of a screening programme, and potentially give men the ‘all-clear for life’ - we take a look at the claims.
BLOG: From 'seek and destroy' radiotherapy to repurposing an ovarian cancer drug, it's been a week of big news from the world's biggest cancer research conference. Dr Matthew Hobbs gives his perspective on the latest in prostate cancer and what needs to happen next.
For the third time in four years, researchers have found a new treatment option to combine with hormone therapy and improve life expectancy for men with advanced prostate cancer.
Allowing men to access test results online provides just as good support while saving the NHS money.
Focal therapy causes fewer side effects when treating localised prostate cancer, so we’re funding a new trial to see if it’s possible to compare it against surgery and radiotherapy.